Ming‐Jong Bair

Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Tung‐Hung Su, Tsung‐Hui Hu, Chi‐Yi Chen et al. · Liver International · 2016 · 221 citations

Pharmacy, Oncology, Pharmacotherapy +17

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Chieh‐Chang Chen, Chih‐Min Chang et al. · The Lancet Infectious Diseases · 2019 · 208 citations

Life Sciences, Microbiology, Pharmacology +17

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Yu-Jen Fang, Chieh‐Chang Chen et al. · The Lancet · 2016 · 202 citations

Medicine, Pharmacology, Pharmacotherapy +7

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A Nationwide Study

Jyh‐Ming Liou, Chi‐Yang Chang, Mei‐Jyh Chen et al. · PLoS ONE · 2015 · 87 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection

Jyh‐Ming Liou, Po‐Yueh Chen, Jiing‐Chyuan Luo et al. · Gastroenterology · 2018 · 85 citations

Life Sciences, Infectious Diseases, Microbiology +11